By Karen Blum
SAN ANTONIO—Less than 10% of patients with new prescriptions for anti-obesity medications actually fill those scripts, and about 30% of anti-obesity medication users are given the medications without a diagnosis code, which could make insurance coverage tricky. These findings, presented as part of two posters at the AMCP 2023 annual meeting, highlight some ongoing challenges with the medications.
JUNE 12, 2023